Ken Lin
About Ken Lin
Ken Lin is a Director at BridgeBio, where he has worked since 2022. He holds a PhD in Biomedical Engineering from UCLA and has extensive experience in materials science and engineering.
Work at BridgeBio
Ken Lin has been serving as Director at BridgeBio since 2022. In this role, he oversees various projects and initiatives within the organization. Prior to his current position, he held the title of Associate Director at BridgeBio from 2021 to 2022. His experience at BridgeBio has contributed to the company's focus on developing innovative therapies.
Education and Expertise
Ken Lin holds a Doctor of Philosophy (PhD) in Biomedical Engineering from UCLA. He also earned both a Bachelor of Science (BS) and a Master of Science (MS) in Materials Science and Engineering from The Johns Hopkins University. His educational background provides a strong foundation in both engineering and biomedical fields.
Background
Before joining BridgeBio, Ken Lin worked at Merck as a Senior Scientist from 2017 to 2021, where he focused on research and development in the pharmaceutical industry. He also served as a Research Chemist at Verseon from 2014 to 2017 in the San Francisco Bay Area. His diverse experience spans both research and applied sciences.
Professional Experience
Ken Lin has accumulated significant experience in the pharmaceutical and biotechnology sectors. His tenure at Verseon and Merck involved various roles that enhanced his expertise in research and development. This experience has been instrumental in his current position at BridgeBio, where he applies his knowledge to advance therapeutic solutions.